Legal Representation
Attorney
Michele K. Robichaux
USPTO Deadlines
Next Deadline
2042 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250819)
Due Date
August 19, 2031
Grace Period Ends
February 19, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 19, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 19, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 25, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 28, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 26, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 26, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 26, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 24, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 24, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 24, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 17, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 17, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 31, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
A full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use by humans for the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders
First Use Anywhere:
Jan 1, 2022
First Use in Commerce:
Apr 1, 2022
Class 036
Providing insurance information in the form of answers to questions from healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance; healthcare insurance administration services in the field of benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing information about healthcare insurance, patient financial assistance, and patient insurance reimbursement programs including enrollment requirements
First Use Anywhere:
Jan 1, 2022
First Use in Commerce:
Apr 11, 2022
Class 041
Providing online non-downloadable videos featuring information regarding therapies and treatment options in the fields of oncology, immunology, and critical care
First Use Anywhere:
Jan 1, 2022
First Use in Commerce:
Apr 17, 2022
Class 044
Providing healthcare and medical information; providing healthcare and medical information in the fields of oncology, immunology, critical care and biosimilars
First Use Anywhere:
Jan 1, 2022
First Use in Commerce:
Nov 29, 2023
Additional Information
Design Mark
The mark consists of the stylized word "accord" where the "a", "r" and "d" are in dark orange and the "c", "c" and "o" are in dark grey. To the right is the stylized word "BioPharma" where "Bio" is in light grey and "Pharma" is in light orange. Above the "rma" portion of "Pharma" are three hexagons in an arch formation. The first hexagon is light grey, the second is dark grey and the third is dark orange.
Color Claim
The colors dark orange, light orange, dark grey, and light grey are claimed as a feature of the mark.
Pseudo Mark
ACCORD BIO PHARMA
Classification
International Classes
005
036
041
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMA"